Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

10.1177/0269881113480990

Saved in:

Bibliographic Details
Main Authors:	Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., Rabiner, E.A., Trist, D., Trower, M., Zamuner, S., Krishnan, R., Fava, M.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Subjects:	clinical trials Depression neurokinin receptor occupancy substance P
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110538
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110538
record_format	dspace
spelling	sg-nus-scholar.10635-1105382024-11-09T20:17:22Z Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies Ratti, E. Bettica, P. Alexander, R. Archer, G. Carpenter, D. Evoniuk, G. Gomeni, R. Lawson, E. Lopez, M. Millns, H. Rabiner, E.A. Trist, D. Trower, M. Zamuner, S. Krishnan, R. Fava, M. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE clinical trials Depression neurokinin receptor occupancy substance P 10.1177/0269881113480990 Journal of Psychopharmacology 27 5 424-434 JOPSE 2014-11-26T09:04:09Z 2014-11-26T09:04:09Z 2013-05 Article Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., Rabiner, E.A., Trist, D., Trower, M., Zamuner, S., Krishnan, R., Fava, M. (2013-05). Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies. Journal of Psychopharmacology 27 (5) : 424-434. ScholarBank@NUS Repository. https://doi.org/10.1177/0269881113480990 02698811 http://scholarbank.nus.edu.sg/handle/10635/110538 000319010100003 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	clinical trials Depression neurokinin receptor occupancy substance P
spellingShingle	clinical trials Depression neurokinin receptor occupancy substance P Ratti, E. Bettica, P. Alexander, R. Archer, G. Carpenter, D. Evoniuk, G. Gomeni, R. Lawson, E. Lopez, M. Millns, H. Rabiner, E.A. Trist, D. Trower, M. Zamuner, S. Krishnan, R. Fava, M. Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
description	10.1177/0269881113480990
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Ratti, E. Bettica, P. Alexander, R. Archer, G. Carpenter, D. Evoniuk, G. Gomeni, R. Lawson, E. Lopez, M. Millns, H. Rabiner, E.A. Trist, D. Trower, M. Zamuner, S. Krishnan, R. Fava, M.
format	Article
author	Ratti, E. Bettica, P. Alexander, R. Archer, G. Carpenter, D. Evoniuk, G. Gomeni, R. Lawson, E. Lopez, M. Millns, H. Rabiner, E.A. Trist, D. Trower, M. Zamuner, S. Krishnan, R. Fava, M.
author_sort	Ratti, E.
title	Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
title_short	Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
title_full	Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
title_fullStr	Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
title_full_unstemmed	Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies
title_sort	full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110538
_version_	1821222385949343744

Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

Similar Items